/Investor DB

U.S. Venture Partners — 2019 Investments

5 investments dated 2019 · listed companies and verified rows first · show all

Happy Returnshappyreturns.comin𝕏Apr 2019

Happy Returns provides a returns and reverse logistics platform for retailers, offering box-free, label-free drop-offs through a network of 10,000 Return Bar locations along with AI-powered fraud detection, item verification, and consolidated returns to warehouses.

E-commerceLogistics & Supply ChainRetail TechVenice, US

David Sobie(Executive Officer, Director)inMark Geller(Executive Officer, Director)inSam E. Kinney(Executive Officer)Brian Spaly(Director)in

BoardGreg Bettinelli(Director)Rick Lewis(Director)in

Co-investorsR/GA VenturesUpfront VenturesUS Venture PartnersLowercase CapitalMaveronPayPal Ventures

Luma Healthlumahealth.ioin𝕏Aug 2019 · $16M

Luma Health builds patient engagement technology that helps healthcare providers connect patients with appointments and manage their clinical, financial, operational, and access journeys.

AI & Machine LearningDigital HealthHealthtechSaaS

Adnan Iqbal(Founder & CEO)inAditya Bansod(Founder)in

Co-investorsAlumni VenturesAzure Capital PartnersCisco InvestmentsCorrelation VenturesEpsilon Health InvestorsFTV Capital+7 more

Neochordneochord.comin𝕏Apr 2019

NeoChord develops a medical device system for beating heart mitral valve repair in patients with mitral valve regurgitation.

Advanced ManufacturingHealthtechMedical DevicesMaple Grove, US

Todd Berg(Executive Officer, Director)inDavid H. Chung(Executive Officer, Director)inRon Nelson(Executive Officer)in

BoardCasey Tansey(Director)Mudit K. Jain(Director)Andrew ElBardissi(Director)in

Co-investorsBaird CapitalTreo Ventures, LlcUS Venture PartnersDeerfield Management Company

Nuvairanuvaira.comin𝕏Feb 2019 · $79M

Nuvaira develops the dNerva Lung Denervation System, a catheter-based device used in a one-time, outpatient bronchoscopic procedure that disrupts pulmonary nerve input to treat chronic obstructive pulmonary disease (COPD).

HardwareHealthtechMedical DevicesMinneapolis, US

Martin Mayse(Founder)inSteve Dimmer(Founder)inDennis Wahr(President & CEO)inLisa Flaherty(Chief Strategy Officer)inSteve Sathre(Vice President of Finance)inSteve Paidosh(Vice President of Operations)

Co-investorsWindham Capital PartnersEndeavour VisionLightstone VenturesMorgenthalerQiming Venture PartnersRichard King Mellon Foundation+2 more

Ribon Therapeuticsribontx.cominJan 2019 · $65M

BiotechLexington, US

Victoria M. Richon(Executive Officer, Director)in

BoardCameron Wheeler(Director)Jonathan Root(Director)Laurence Lasky(Director)

Co-investorsAvego BioScience CapitalOUP (Osage University Partners)Peregrine VenturesAbbVieDeerfield Management CompanyJJDC+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.